Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$77.07 - $87.05 $4.64 Million - $5.24 Million
-60,146 Reduced 18.26%
269,166 $22.7 Million
Q3 2023

Nov 14, 2023

SELL
$83.86 - $99.16 $990,051 - $1.17 Million
-11,806 Reduced 3.46%
329,312 $28.3 Million
Q2 2023

Aug 14, 2023

SELL
$87.76 - $99.95 $765,442 - $871,763
-8,722 Reduced 2.49%
341,118 $31.8 Million
Q1 2023

May 15, 2023

BUY
$87.14 - $100.3 $690,497 - $794,777
7,924 Added 2.32%
349,840 $33.2 Million
Q4 2022

Feb 14, 2023

SELL
$82.45 - $101.88 $22,343 - $27,609
-271 Reduced 0.08%
341,916 $34.4 Million
Q3 2022

Nov 14, 2022

BUY
$80.73 - $95.26 $27.6 Million - $32.6 Million
342,187 New
342,187 $29.2 Million

Others Institutions Holding UTMD

About UTAH MEDICAL PRODUCTS INC


  • Ticker UTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 3,625,200
  • Market Cap $237M
  • Description
  • Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO u...
More about UTMD
Track This Portfolio

Track T. Rowe Price Investment Management, Inc. Portfolio

Follow T. Rowe Price Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.